Cassell S - Search Results

1

Outcome measures in psoriatic arthritis.

Kavanaugh A, Cassell S. Kavanaugh A, et al. Among authors: cassell s. Curr Rheumatol Rep. 2005 Jun;7(3):195-200. doi: 10.1007/s11926-996-0039-x. Curr Rheumatol Rep. 2005. PMID: 15918995 Review.

2

The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.

Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A. Cassell SE, et al. J Rheumatol. 2007 Jan;34(1):123-9. J Rheumatol. 2007. PMID: 17216680

3

The assessment of disease activity and outcomes in psoriatic arthritis.

Kavanaugh A, Cassell S. Kavanaugh A, et al. Among authors: cassell s. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S142-7. Clin Exp Rheumatol. 2005. PMID: 16273798 Review.

4

Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatment.

Cassell S, Kavanaugh A. Cassell S, et al. J Immune Based Ther Vaccines. 2005 Sep 2;3:6. doi: 10.1186/1476-8518-3-6. J Immune Based Ther Vaccines. 2005. PMID: 16138929 Free PMC article.

5

Therapies for psoriatic nail disease. A systematic review.

Cassell S, Kavanaugh AF. Cassell S, et al. J Rheumatol. 2006 Jul;33(7):1452-6. Epub 2006 May 15. J Rheumatol. 2006. PMID: 16724366 Review.

6

Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.

Curtis JR, Beukelman T, Onofrei A, Cassell S, Greenberg JD, Kavanaugh A, Reed G, Strand V, Kremer JM. Curtis JR, et al. Among authors: cassell s. Ann Rheum Dis. 2010 Jan;69(1):43-7. doi: 10.1136/ard.2008.101378. Ann Rheum Dis. 2010. PMID: 19147616 Free PMC article.

7

Patient assessments of skin, joint, and nail disease activity in psoriatic arthritis.

Kavanaugh A, Catalan T, Cassell S. Kavanaugh A, et al. Among authors: cassell s. J Rheumatol. 2012 Mar;39(3):653; author reply 654. doi: 10.3899/jrheum.110839. J Rheumatol. 2012. PMID: 22383354 No abstract available.

8

A strategy for reaching therapeutic salicylate levels in patients with rheumatoid arthritis using standardized dosing regimens.

Furst DE, Blocka K, Cassell S, Dromgoole S, Harris ER, Hirschberg JM, Josephson N, Rupp PA, Paulus HE, Trimble RB. Furst DE, et al. Among authors: cassell s. J Rheumatol. 1987 Apr;14(2):342-7. J Rheumatol. 1987. PMID: 3599003

9

Steady-state serum salicylate levels in hospitalized patients with rheumatoid arthritis. Comparison of two dosage schedules of choline magnesium trisalicylate.

Cassell S, Furst D, Dromgoole S, Paulus H. Cassell S, et al. Arthritis Rheum. 1979 Apr;22(4):384-8. doi: 10.1002/art.1780220411. Arthritis Rheum. 1979. PMID: 426883

10

A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritis.

Furst DE, Blocka K, Cassell S, Harris ER, Hirschberg JM, Josephson N, Lachenbruch PA, Trimble RB, Paulus HE. Furst DE, et al. Among authors: cassell s. Arthritis Rheum. 1987 Feb;30(2):146-54. doi: 10.1002/art.1780300204. Arthritis Rheum. 1987. PMID: 3548732 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters